thiabendazole has been researched along with Stevens-Johnson Syndrome in 2 studies
Tresaderm: dermatologic soln containing dexamethasone, thiabendazole & neomycin sulfate
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
Excerpt | Relevance | Reference |
---|---|---|
"The rashes were compatible with erythema multiforme and Stevens-Johnson syndrome and developed in the three siblings within 1-3 weeks after the intake of thiabendazole." | 3.72 | Severe drug rashes in three siblings simultaneously. ( Bahna, SL; Johnson-Reagan, L, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Johnson-Reagan, L | 1 |
Bahna, SL | 1 |
Robinson, HM | 1 |
Samorodin, CS | 1 |
2 other studies available for thiabendazole and Stevens-Johnson Syndrome
Article | Year |
---|---|
Severe drug rashes in three siblings simultaneously.
Topics: Antinematodal Agents; Child; Child, Preschool; Drug Hypersensitivity; Female; Humans; Male; Siblings | 2003 |
Thiabendazole-induced toxic epidermal necrolysis.
Topics: Adult; Female; Humans; Stevens-Johnson Syndrome; Thiabendazole; Trichuriasis | 1976 |